Harrow Health, Revenue Per Share Over Time
| HROWM Stock | 26.24 0.14 0.54% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Harrow Health, Performance and Harrow Health, Correlation. Harrow |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health,. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health, 11875 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health,'s value that differs from its market value or its book value, called intrinsic value, which is Harrow Health,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health,'s market value can be influenced by many factors that don't directly affect Harrow Health,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Revenue Per Share Analysis
Compare Harrow Health, 11875 and related stocks such as Harrow Health 8625, Babcock Wilcox Enter, and Runway Growth Finance Revenue Per Share Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HROWL | 0.0223 | 0.0223 | 0.0223 | 0.0012 | 0.1818 | 1.0146 | 1.5649 | 1.3404 | 1.7374 | 2.0205 | 1.8872 | 2.7086 | 3.2262 | 3.9916 | 4.19 |
| BWSN | 172 | 172 | 172 | 165 | 148 | 164 | 157 | 165 | 76.8232 | 27.2609 | 11.6259 | 8.7801 | 10.082 | 11.2273 | 10.67 |
| RWAYZ | 1.1412 | 1.1412 | 1.1412 | 1.1412 | 1.1412 | 1.1412 | 1.1412 | 1.1412 | 0.3395 | 0.7658 | 1.2416 | 1.306 | 1.0296 | 3.5997 | 3.78 |
| RWAYL | 1.1412 | 1.1412 | 1.1412 | 1.1412 | 1.1412 | 1.1412 | 1.1412 | 1.1412 | 0.3395 | 0.7658 | 1.2416 | 1.306 | 1.0296 | 3.5997 | 3.78 |
Harrow Health, 11875 and related stocks such as Harrow Health 8625, Babcock Wilcox Enter, and Runway Growth Finance Revenue Per Share description
The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.My Equities
My Current Equities and Potential Positions
| Harrow Health, 11875 | HROWM |
Specialization | Healthcare, Drug Manufacturers - Specialty & Generic |
| Exchange | NASDAQ Exchange |
null 26.24
Check out Harrow Health, Performance and Harrow Health, Correlation. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Harrow Health, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.